An review of the TNOA Cornea Masterclass discussion on how emerging corneal cross-linking protocols balance procedural efficiency with the necessity of biomechanical efficacy.
ELZA’s CEO and CMO, Nikki and Farhad Hafezi flew to Hong Kong to attend APAO 2026, including an invited symposium presentation by Prof. Farhad Hafezi on Custom CXL.
Swiss newspapers report on a severe contact lens–related eye infection and how an innovative treatment at ELZA Institute helped save vision.
“The eye, once thought sterile and immunoprivileged, is entangled in systemic crosstalk between microbial tenants and ocular health.”
At Swiss Eye Week 2026 in Thun, Prof Farhad Hafezi contributed to ophthalmology education with lectures on corneal cross-linking and ectasia rehabilitation.
Prof Farhad Hafezi represented the ELZA Institute at Keracon 2025 in Goa, contributing invited lectures on evidence-based advances in corneal cross-linking and ectasia management.
Prof. Farhad Hafezi presented five-year outcomes and future directions of the sub400 protocol for thin cornea CXL at the KCXL Experts’ Meeting 2025 in Milan.
Prof. Hafezi presented new insights on PACK-CXL, ELZA-PACE, and epi-on CXL at EPOMEC 2025, shaping future keratoconus management.
Ten years after the First Global Consensus, the Second Global Consensus on Keratoconus—reported in EuroTimes—provides an updated, internationally agreed framework for diagnosis, staging, and management. Developed using a modified Delphi process, it reflects a shift from disease stabilisation alone toward individualized care that integrates modern diagnostics, optimized cross-linking strategies, and visual rehabilitation.
ECO-CAIRS, developed at ELZA, uses ultra-high-fluence CXL to optimize donor corneal ring segments for keratoconus surgery. Now published in JRS.
